These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A study of the effects of various drugs used in treatment of paralysis agitans. KAPLAN HA; MACHOVER S; BROWDER J; RABINER AM AMA Arch Neurol Psychiatry; 1952 Jun; 67(6):828-9. PubMed ID: 14923024 [No Abstract] [Full Text] [Related]
24. [Experience with disipal (BS 5930) in paralysis agitans]. KOSTER S Geneeskd Gids; 1955 Jul; 33(15):302-8. PubMed ID: 13251449 [No Abstract] [Full Text] [Related]
25. The psychotherapy of paralysis agitans. DOSHAY LJ J Am Med Assoc; 1960 Mar; 172():1347-51. PubMed ID: 13817741 [No Abstract] [Full Text] [Related]
26. Use of tolbutamide in paralysis agitans: preliminary report. GATES EW; HYMAN I J Am Med Assoc; 1960 Mar; 172():1351-4. PubMed ID: 13826835 [No Abstract] [Full Text] [Related]
27. [Utilization of synergistic and associated movements in the rehabilitation of paralysis]. SIMARRO-PUIG J Rev Clin Esp; 1953 May; 49(4):239-40. PubMed ID: 13089197 [No Abstract] [Full Text] [Related]
28. AGENTS for treatment of Parkinson's disease. N Engl J Med; 1957 Apr; 256(15):699-701. PubMed ID: 13451922 [No Abstract] [Full Text] [Related]
29. [Activity of kemadrin on the symptoms of Parkinson's disease; comparison with other therapeutics]. SIGWALD J Presse Med (1893); 1953 Jan; 61(7):127-8. PubMed ID: 13055735 [No Abstract] [Full Text] [Related]
30. [Treatment of Parkinson disease]. PORTELLA A Rass Int Clin Ter; 1954 Apr; 34(8):253-5. PubMed ID: 13177940 [No Abstract] [Full Text] [Related]
31. [Synthetic drugs in the therapy of morbus Parkinson]. LEHOCZKY T Schweiz Med Wochenschr; 1952 Sep; 82(36):904-6. PubMed ID: 12994820 [No Abstract] [Full Text] [Related]
32. [ON the medicinal treatment of the Parkinson syndrome]. Medizinische; 1959 Dec; 50():2490-3. PubMed ID: 13857686 [No Abstract] [Full Text] [Related]
33. Tranquilizing (ataractic) agents: current evaluation of their clinical use in patients who are not hospitalized. MOYER JH; PEVEY K; KINROSS-WRIGHT V GP; 1957 Jun; 15(6):97-118. PubMed ID: 13427919 [No Abstract] [Full Text] [Related]
34. Paralysis agitans syndrome: a report of the results of testing and treatment with high frequency (sedac) currents. EYRES AE Dis Nerv Syst; 1961 Apr; 22(4)Suppl():86-9. PubMed ID: 13697726 [No Abstract] [Full Text] [Related]
35. Paralysis agitans syndrome. A report on the results of testing and treatment with high frequency (sedac) currents. EYRES AE; KNIGHT J; REITER R J Mich State Med Soc; 1961 Jun; 60():775-82. PubMed ID: 13697725 [No Abstract] [Full Text] [Related]
37. [The so-called "tranquilizing" agents]. BURGERMEISTER JJ; DICK P Rev Med Suisse Romande; 1959 Dec; 79():850-6. PubMed ID: 13806072 [No Abstract] [Full Text] [Related]
38. [Clinical study of trihexyphenyl-HCl therapy of the parkinson syndrome]. AKIMOTO H; SHIKIBA S; NAGAO T; NARABAYASHI H No To Shinkei; 1961 Sep; 13():721-4. PubMed ID: 13859932 [No Abstract] [Full Text] [Related]
39. [Use of tranquilizing agents in pediatrics]. HO BT Zhonghua Er Ke Za Zhi; 1960 Jan; 11():78-81. PubMed ID: 13907848 [No Abstract] [Full Text] [Related]
40. [Management of tranquilizing drugs in pediatrics]. BORBOLLA VACHER L Rev Cubana Pediatr; 1959 Oct; 31():557-74. PubMed ID: 13802708 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]